# Vietnam Veterans Liver Fluke Cancer Study Act

This bill directs the Department of Veterans Affairs to investigate whether Vietnam War veterans have higher rates of a specific type of cancer called cholangiocarcinoma, which is a cancer of the bile ducts in the liver. The concern stems from the fact that soldiers who served in Vietnam may have been exposed to parasitic liver flukes through contaminated food and water, and these parasites are known to increase cancer risk. The bill essentially asks the government to find out if this exposure actually led to more cases of this cancer among veterans compared to the general American population.

Here's what will actually happen: The VA, working with the Centers for Disease Control and Prevention, has 120 days to start a study using existing cancer registry data to compare how often this cancer appears in Vietnam veterans versus other Americans. They'll look at when people were diagnosed, their age, gender, race, and where they lived. Within a year of completing the study, the VA must report their findings to Congress along with recommendations about what should be done next—whether that means new benefits, better screening programs, or other support for affected veterans.

The bill also requires the VA to keep tracking this cancer in Vietnam veterans going forward and provide updated reports to Congress periodically. This is important because it could eventually lead to the government recognizing cholangiocarcinoma as a service-connected condition, which would make veterans with this cancer eligible for disability benefits and healthcare coverage through the VA. Right now, without this study, there's no official acknowledgment of a link between Vietnam service and this particular cancer, so veterans suffering from it may struggle to get benefits.

Vietnam Veterans Liver Fluke Cancer Study Act

Zeldin, Lee M.

Vietnam Veterans Liver Fluke Cancer Study Act This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study shall identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents. The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry.